Race Oncology, EZZ Life Science and Neurotech International are among ASX health companies reporting quarterly results.

Advances 5x30 strategy by expanding pipeline with a highly complementary asset that has the potential to provide several days ...

With the rise of “Protein Maxing” among biohackers, fitness influencers, and health-conscious consumers, a major controversy has emerged that ...

On November 5, SK Biopharm announced that it recorded third-quarter sales and operating profit that exceeded market expectations, driven by the rapid ...

The Global Tube Packaging Market Size is projected to grow at a CAGR of 6.82% from 2026 to 2032, according to a new report ...

Datavault AI believes this technology has the potential to extend into a Pharmaceutical Exchange platform, which could transform the pharmaceutical industry by enabling efficient, secure asset ...

Cipla has agreed to acquire a 100% stake in Inzpera Healthsciences, making it a wholly owned subsidiary, as part of its ...

Cash balance of $344.8 million as of September 30, 2025, together with net proceeds of ~$445 million from October 2025 equity offering, with expected runway into 2028 BEDFORD, Mass., Nov. 04, 2025 ...

The world of discontinued beverage collecting is surprisingly lucrative, with passionate enthusiasts paying hundreds or even thousands of dollars for sips of the past. These liquid time capsules ...